Viewing Study NCT05011669


Ignite Creation Date: 2025-12-24 @ 11:13 PM
Ignite Modification Date: 2025-12-25 @ 8:49 PM
Study NCT ID: NCT05011669
Status: COMPLETED
Last Update Posted: 2024-04-18
First Post: 2021-08-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: The Safety and Efficacy of Lurasidone With Different Initiation Dose in Chinese Acute Phase Patients With Schizophrenia
Sponsor: Sumitomo Pharma (Suzhou) Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module